| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 18 |
| 1 | METHOTREXATE | 4 |
| 2 | METHOTREXATE SODIUM | 4 |
| 3 | OMEPRAZOLE MAGNESIUM | 4 |
| 4 | ALENDRONATE SODIUM | 3 |
| 5 | CELECOXIB | 3 |
| 6 | ESOMEPRAZOLE MAGNESIUM | 3 |
| 7 | FUROSEMIDE | 3 |
| 8 | SECUKINUMAB | 3 |
| 9 | SIMVASTATIN | 3 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | NATEGLINIDE | 1 | 0.0007 |
| 1 | FOSINOPIRL SODIUM | 1 | 0.0005 |
| 2 | INFLIXIMAB-DYYB | 1 | 0.0003 |
| 3 | FOSINOPRIL | 1 | 0.0002 |
| 4 | FINGOLIMOD HYDROCHLORIDE | 1 | 0.0002 |
| 5 | TEDUGLUTIDE | 2 | 0.0001 |
| 6 | FOSTAMATINIB | 1 | 0.0001 |
| 7 | MEPERIDINE HYDROCHLORIDE | 1 | 0.0001 |
| 8 | BLINATUMOMAB | 1 | 0.0001 |
| 9 | CEPHALEXIN | 2 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | GLP-2 Analog [EPC] | 2 | 0.0001 |
| 1 | Glinide [EPC] | 1 | 0.0001 |
| 2 | Interleukin-17A Antagonist [EPC] | 3 | 0.0001 |
| 3 | Provitamin D2 Compound [EPC] | 2 | 0.0001 |
| 4 | Bile Acid [EPC] | 1 | 0.0000 |
| 5 | Antimycobacterial [EPC] | 1 | 0.0000 |
| 6 | Complement Inhibitor [EPC] | 1 | 0.0000 |
| 7 | Methylxanthine [EPC] | 1 | 0.0000 |
| 8 | P2Y12 Platelet Inhibitor [EPC] | 2 | 0.0000 |
| 9 | Cholinergic Nicotinic Agonist [EPC] | 1 | 0.0000 |